# Efficacy and Safety of Hou Gu Mi Xi in Patients With Spleen Qi Deficiency and Radical Gastrectomy for Gastric Cancer

> **NCT03025152** · NA · TERMINATED · sponsor: **Jiangxi University of Traditional Chinese Medicine** · enrollment: 130 (actual)

## Conditions studied

- Gastric Cancer
- Gastrointestinal Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Hou Gu Mi Xi
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT03025152
- **Lead sponsor:** Jiangxi University of Traditional Chinese Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-11-11
- **Primary completion:** 2019-07-20
- **Final completion:** 2019-07-20
- **Target enrollment:** 130 (ACTUAL)
- **Why stopped:** High attrition rate up to 37.7% at one year's follow-up
- **Last updated:** 2021-04-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03025152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03025152, "Efficacy and Safety of Hou Gu Mi Xi in Patients With Spleen Qi Deficiency and Radical Gastrectomy for Gastric Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03025152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*